QURE - uniQure N.V.
IEX Last Trade
5.85
-0.370 -6.325%
Share volume: 439,477
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.22
-0.37
-5.95%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-27 | 2023-05-09 | 2023-08-01 | 2023-11-07 | 2024-02-28 | 2024-05-07 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 638.234 M | 704.964 M | 631.004 M | 942.769 M | 871.550 M | 831.689 M | 770.050 M | 730.846 M | |
| Current Assets | 464.577 M | 476.774 M | 442.643 M | 756.959 M | 693.626 M | 651.853 M | 596.003 M | 591.968 M | |
| Inventories | 4.075 M | 6.924 M | 7.477 M | 10.212 M | 15.654 M | 12.024 M | 7.672 M | 0.000 | |
| Other Current Assets | 16.586 M | 14.631 M | 15.035 M | 15.601 M | 17.416 M | 17.744 M | 21.931 M | 21.724 M | |
| Short Term Investments | 16.586 M | 14.631 M | 15.035 M | 15.601 M | 17.416 M | 17.744 M | 21.931 M | 21.724 M | |
| Total Receivables | 3.603 M | 102.376 M | 104.793 M | 102.559 M | 1.644 M | 4.193 M | 10.717 M | 7.850 M | |
| Current Cash | 440.313 M | 352.843 M | 315.338 M | 628.587 M | 658.912 M | 617.892 M | 555.683 M | 524.430 M | |
| Total Non-current Assets | 173.657 M | 228.190 M | 188.361 M | 185.810 M | 177.924 M | 179.836 M | 174.047 M | 138.878 M | |
| Property Plant Equipment | 47.886 M | 50.532 M | 50.072 M | 48.567 M | 45.946 M | 46.548 M | 44.554 M | 26.186 M | |
| Other Assets | 6.085 M | 6.061 M | 6.121 M | 6.124 M | 6.018 M | 5.363 M | 5.298 M | 5.278 M | |
| Intangible Assets | 53.837 M | 58.778 M | 59.704 M | 59.713 M | 57.976 M | 60.481 M | 59.111 M | 58.659 M | |
| Goodwill | 23.418 M | 25.581 M | 25.998 M | 26.016 M | 25.273 M | 26.379 M | 25.795 M | 23.112 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 638.234 M | 704.964 M | 631.004 M | 942.769 M | 871.550 M | 831.689 M | 770.050 M | 730.846 M | |
| Total liabilities | 217.064 M | 228.955 M | 218.233 M | 589.449 M | 602.766 M | 624.019 M | 623.296 M | 633.739 M | |
| Total current liabilities | 63.974 M | 75.919 M | 66.336 M | 68.356 M | 68.607 M | 73.675 M | 63.473 M | 80.468 M | |
| Accounts Payable | 7.566 M | 10.984 M | 8.885 M | 9.373 M | 5.584 M | 6.586 M | 5.231 M | 4.407 M | |
| Other liabilities | 12.211 M | 10.269 M | 10.599 M | 382.986 M | 398.834 M | 412.736 M | 423.344 M | 431.072 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 102.394 M | 102.791 M | 103.253 M | 101.110 M | 101.431 M | 101.749 M | 102.120 M | 102.507 M | |
| Other liabilities | 12.211 M | 10.269 M | 10.599 M | 382.986 M | 398.834 M | 412.736 M | 423.344 M | 431.072 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 421.170 M | 476.009 M | 412.771 M | 353.320 M | 268.784 M | 207.670 M | 146.754 M | 97.107 M | |
| Common stock | 46.772 M | 46.900 M | 47.436 M | 47.650 M | 47.770 M | 47.828 M | 48.385 M | 48.622 M | |
| Retained earnings | -588.738 M | -581.931 M | -659.158 M | -727.632 M | -817.203 M | -890.409 M | -956.027 M | -1.012 B |